Review





Similar Products

ultrafast dce mri  (Philips Healthcare)
86
Philips Healthcare ultrafast dce mri
Ultrafast Dce Mri, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ultrafast dce mri/product/Philips Healthcare
Average 86 stars, based on 1 article reviews
ultrafast dce mri - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
dce mri measurement  (Philips Healthcare)
86
Philips Healthcare dce mri measurement
Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
Dce Mri Measurement, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dce mri measurement/product/Philips Healthcare
Average 86 stars, based on 1 article reviews
dce mri measurement - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
dce mri  (Bruker Corporation)
97
Bruker Corporation dce mri
Treatment window expansion by ML‐CL. (A) Experimental workflow for all MB‐FUS controllers. (B) Cavitation threshold model from the training dataset, showing 7th harmonic AE vs. pressure; 36 dB target level was chosen above the model. (C) ML‐CL pressure decisions (left) and corresponding P Max and P Avg used for OL controllers (right); OL's pressure reduction indicates response to broadband emission events (> 6 dB). D) Representative MRI image for 36 dB target level sonication targets. Total 4 targets per mouse. (E) 7th harmonic emissions during sonication for each controller. P Avg :36.2 ± 3.3 dB, P Max 37.9 ± 2.4 dB, CL:35.1 ± 0.7 dB, ML‐CL:34.7 ± 0.7 dB. n = 8 targets (total 2 animals) per group. (F) Mean (left) and standard deviation (right) of 7 th harmonic emission during sonication by ML‐CL. A variance test ( f ‐test) was performed to compare the standard deviation (right) of the mean 7th harmonic emission at each target. (G) MRI T1 images using the controller at 36 dB or equivalent OL pressure. (H) Quantification of K trans values through <t>DCE‐MRI.</t> (I) Broadband emission histogram (>6 dB considered an event). 11, 46, 14, and 1 instances of broadband emission event out of 1048 total sonications for P Avg , P Max , CL, and ML‐CL, respectively. (J) MLP decision histogram for ML‐CL. 4.4% positive predictions. (46/1040 of sonication). (K) Treatment window analysis for reactive (OL, CL) and predictive (ML‐CL) controllers, showing a ∼300% expansion with ML‐CL (0.09 vs. 0.02 MPa for OL/CL) and a 188% shift in K trans ‐to‐broadband probability curve, indicating improved BBB opening at matched safety. A more detailed figure with individual data points is shown in Figure . ns = not significant, * p < 0.05, and ** p < 0.01. Statistical analyses were performed through One‐way ANOVA and Bonferroni correction. For the variance test, f ‐test was used with Bonferroni correction.
Dce Mri, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dce mri/product/Bruker Corporation
Average 97 stars, based on 1 article reviews
dce mri - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier
dce mri  (Hirschmann)
86
Hirschmann dce mri
Treatment window expansion by ML‐CL. (A) Experimental workflow for all MB‐FUS controllers. (B) Cavitation threshold model from the training dataset, showing 7th harmonic AE vs. pressure; 36 dB target level was chosen above the model. (C) ML‐CL pressure decisions (left) and corresponding P Max and P Avg used for OL controllers (right); OL's pressure reduction indicates response to broadband emission events (> 6 dB). D) Representative MRI image for 36 dB target level sonication targets. Total 4 targets per mouse. (E) 7th harmonic emissions during sonication for each controller. P Avg :36.2 ± 3.3 dB, P Max 37.9 ± 2.4 dB, CL:35.1 ± 0.7 dB, ML‐CL:34.7 ± 0.7 dB. n = 8 targets (total 2 animals) per group. (F) Mean (left) and standard deviation (right) of 7 th harmonic emission during sonication by ML‐CL. A variance test ( f ‐test) was performed to compare the standard deviation (right) of the mean 7th harmonic emission at each target. (G) MRI T1 images using the controller at 36 dB or equivalent OL pressure. (H) Quantification of K trans values through <t>DCE‐MRI.</t> (I) Broadband emission histogram (>6 dB considered an event). 11, 46, 14, and 1 instances of broadband emission event out of 1048 total sonications for P Avg , P Max , CL, and ML‐CL, respectively. (J) MLP decision histogram for ML‐CL. 4.4% positive predictions. (46/1040 of sonication). (K) Treatment window analysis for reactive (OL, CL) and predictive (ML‐CL) controllers, showing a ∼300% expansion with ML‐CL (0.09 vs. 0.02 MPa for OL/CL) and a 188% shift in K trans ‐to‐broadband probability curve, indicating improved BBB opening at matched safety. A more detailed figure with individual data points is shown in Figure . ns = not significant, * p < 0.05, and ** p < 0.01. Statistical analyses were performed through One‐way ANOVA and Bonferroni correction. For the variance test, f ‐test was used with Bonferroni correction.
Dce Mri, supplied by Hirschmann, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dce mri/product/Hirschmann
Average 86 stars, based on 1 article reviews
dce mri - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
dce mri  (Jiangsu Hengrui Medicine)
86
Jiangsu Hengrui Medicine dce mri
Treatment window expansion by ML‐CL. (A) Experimental workflow for all MB‐FUS controllers. (B) Cavitation threshold model from the training dataset, showing 7th harmonic AE vs. pressure; 36 dB target level was chosen above the model. (C) ML‐CL pressure decisions (left) and corresponding P Max and P Avg used for OL controllers (right); OL's pressure reduction indicates response to broadband emission events (> 6 dB). D) Representative MRI image for 36 dB target level sonication targets. Total 4 targets per mouse. (E) 7th harmonic emissions during sonication for each controller. P Avg :36.2 ± 3.3 dB, P Max 37.9 ± 2.4 dB, CL:35.1 ± 0.7 dB, ML‐CL:34.7 ± 0.7 dB. n = 8 targets (total 2 animals) per group. (F) Mean (left) and standard deviation (right) of 7 th harmonic emission during sonication by ML‐CL. A variance test ( f ‐test) was performed to compare the standard deviation (right) of the mean 7th harmonic emission at each target. (G) MRI T1 images using the controller at 36 dB or equivalent OL pressure. (H) Quantification of K trans values through <t>DCE‐MRI.</t> (I) Broadband emission histogram (>6 dB considered an event). 11, 46, 14, and 1 instances of broadband emission event out of 1048 total sonications for P Avg , P Max , CL, and ML‐CL, respectively. (J) MLP decision histogram for ML‐CL. 4.4% positive predictions. (46/1040 of sonication). (K) Treatment window analysis for reactive (OL, CL) and predictive (ML‐CL) controllers, showing a ∼300% expansion with ML‐CL (0.09 vs. 0.02 MPa for OL/CL) and a 188% shift in K trans ‐to‐broadband probability curve, indicating improved BBB opening at matched safety. A more detailed figure with individual data points is shown in Figure . ns = not significant, * p < 0.05, and ** p < 0.01. Statistical analyses were performed through One‐way ANOVA and Bonferroni correction. For the variance test, f ‐test was used with Bonferroni correction.
Dce Mri, supplied by Jiangsu Hengrui Medicine, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dce mri/product/Jiangsu Hengrui Medicine
Average 86 stars, based on 1 article reviews
dce mri - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
dce mri  (Bayer Schering Pharma)
86
Bayer Schering Pharma dce mri
Treatment window expansion by ML‐CL. (A) Experimental workflow for all MB‐FUS controllers. (B) Cavitation threshold model from the training dataset, showing 7th harmonic AE vs. pressure; 36 dB target level was chosen above the model. (C) ML‐CL pressure decisions (left) and corresponding P Max and P Avg used for OL controllers (right); OL's pressure reduction indicates response to broadband emission events (> 6 dB). D) Representative MRI image for 36 dB target level sonication targets. Total 4 targets per mouse. (E) 7th harmonic emissions during sonication for each controller. P Avg :36.2 ± 3.3 dB, P Max 37.9 ± 2.4 dB, CL:35.1 ± 0.7 dB, ML‐CL:34.7 ± 0.7 dB. n = 8 targets (total 2 animals) per group. (F) Mean (left) and standard deviation (right) of 7 th harmonic emission during sonication by ML‐CL. A variance test ( f ‐test) was performed to compare the standard deviation (right) of the mean 7th harmonic emission at each target. (G) MRI T1 images using the controller at 36 dB or equivalent OL pressure. (H) Quantification of K trans values through <t>DCE‐MRI.</t> (I) Broadband emission histogram (>6 dB considered an event). 11, 46, 14, and 1 instances of broadband emission event out of 1048 total sonications for P Avg , P Max , CL, and ML‐CL, respectively. (J) MLP decision histogram for ML‐CL. 4.4% positive predictions. (46/1040 of sonication). (K) Treatment window analysis for reactive (OL, CL) and predictive (ML‐CL) controllers, showing a ∼300% expansion with ML‐CL (0.09 vs. 0.02 MPa for OL/CL) and a 188% shift in K trans ‐to‐broadband probability curve, indicating improved BBB opening at matched safety. A more detailed figure with individual data points is shown in Figure . ns = not significant, * p < 0.05, and ** p < 0.01. Statistical analyses were performed through One‐way ANOVA and Bonferroni correction. For the variance test, f ‐test was used with Bonferroni correction.
Dce Mri, supplied by Bayer Schering Pharma, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dce mri/product/Bayer Schering Pharma
Average 86 stars, based on 1 article reviews
dce mri - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
dedicated dce mri software  (Siemens Healthineers)
86
Siemens Healthineers dedicated dce mri software
Treatment window expansion by ML‐CL. (A) Experimental workflow for all MB‐FUS controllers. (B) Cavitation threshold model from the training dataset, showing 7th harmonic AE vs. pressure; 36 dB target level was chosen above the model. (C) ML‐CL pressure decisions (left) and corresponding P Max and P Avg used for OL controllers (right); OL's pressure reduction indicates response to broadband emission events (> 6 dB). D) Representative MRI image for 36 dB target level sonication targets. Total 4 targets per mouse. (E) 7th harmonic emissions during sonication for each controller. P Avg :36.2 ± 3.3 dB, P Max 37.9 ± 2.4 dB, CL:35.1 ± 0.7 dB, ML‐CL:34.7 ± 0.7 dB. n = 8 targets (total 2 animals) per group. (F) Mean (left) and standard deviation (right) of 7 th harmonic emission during sonication by ML‐CL. A variance test ( f ‐test) was performed to compare the standard deviation (right) of the mean 7th harmonic emission at each target. (G) MRI T1 images using the controller at 36 dB or equivalent OL pressure. (H) Quantification of K trans values through <t>DCE‐MRI.</t> (I) Broadband emission histogram (>6 dB considered an event). 11, 46, 14, and 1 instances of broadband emission event out of 1048 total sonications for P Avg , P Max , CL, and ML‐CL, respectively. (J) MLP decision histogram for ML‐CL. 4.4% positive predictions. (46/1040 of sonication). (K) Treatment window analysis for reactive (OL, CL) and predictive (ML‐CL) controllers, showing a ∼300% expansion with ML‐CL (0.09 vs. 0.02 MPa for OL/CL) and a 188% shift in K trans ‐to‐broadband probability curve, indicating improved BBB opening at matched safety. A more detailed figure with individual data points is shown in Figure . ns = not significant, * p < 0.05, and ** p < 0.01. Statistical analyses were performed through One‐way ANOVA and Bonferroni correction. For the variance test, f ‐test was used with Bonferroni correction.
Dedicated Dce Mri Software, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dedicated dce mri software/product/Siemens Healthineers
Average 86 stars, based on 1 article reviews
dedicated dce mri software - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).

Journal: Frontiers in Oncology

Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

doi: 10.3389/fonc.2026.1714620

Figure Lengend Snippet: Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).

Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

Techniques: Diffusion-based Assay

Representative images of a non-TNBC lesion (Luminal B subtype, Invasive Ductal Carcinoma, Ki-67: 30%) in the left breast. The tumor exhibits an irregular shape with spiculation and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing a plateau pattern (Type II).

Journal: Frontiers in Oncology

Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

doi: 10.3389/fonc.2026.1714620

Figure Lengend Snippet: Representative images of a non-TNBC lesion (Luminal B subtype, Invasive Ductal Carcinoma, Ki-67: 30%) in the left breast. The tumor exhibits an irregular shape with spiculation and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing a plateau pattern (Type II).

Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

Techniques:

Receiver operating characteristic (ROC) curves evaluating the diagnostic performance of different MRI parameters and models for distinguishing TNBC from non-TNBC. (A) ROC curves of individual DCE-MRI parameters (RE, ME, WI, WO) and their combination. (B) ROC curves of quantitative mapping parameters (Enhanced T1, ΔT1%, T2) and their combination. (C) Comparison of diagnostic performance among the DCE-MRI model, Quantitative Mapping model, and the Combined Model (DCE-MRI + Quantitative Mapping). The Combined Model achieved the highest Area Under the Curve (AUC = 0.977).

Journal: Frontiers in Oncology

Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

doi: 10.3389/fonc.2026.1714620

Figure Lengend Snippet: Receiver operating characteristic (ROC) curves evaluating the diagnostic performance of different MRI parameters and models for distinguishing TNBC from non-TNBC. (A) ROC curves of individual DCE-MRI parameters (RE, ME, WI, WO) and their combination. (B) ROC curves of quantitative mapping parameters (Enhanced T1, ΔT1%, T2) and their combination. (C) Comparison of diagnostic performance among the DCE-MRI model, Quantitative Mapping model, and the Combined Model (DCE-MRI + Quantitative Mapping). The Combined Model achieved the highest Area Under the Curve (AUC = 0.977).

Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

Techniques: Diagnostic Assay, Comparison

Treatment window expansion by ML‐CL. (A) Experimental workflow for all MB‐FUS controllers. (B) Cavitation threshold model from the training dataset, showing 7th harmonic AE vs. pressure; 36 dB target level was chosen above the model. (C) ML‐CL pressure decisions (left) and corresponding P Max and P Avg used for OL controllers (right); OL's pressure reduction indicates response to broadband emission events (> 6 dB). D) Representative MRI image for 36 dB target level sonication targets. Total 4 targets per mouse. (E) 7th harmonic emissions during sonication for each controller. P Avg :36.2 ± 3.3 dB, P Max 37.9 ± 2.4 dB, CL:35.1 ± 0.7 dB, ML‐CL:34.7 ± 0.7 dB. n = 8 targets (total 2 animals) per group. (F) Mean (left) and standard deviation (right) of 7 th harmonic emission during sonication by ML‐CL. A variance test ( f ‐test) was performed to compare the standard deviation (right) of the mean 7th harmonic emission at each target. (G) MRI T1 images using the controller at 36 dB or equivalent OL pressure. (H) Quantification of K trans values through DCE‐MRI. (I) Broadband emission histogram (>6 dB considered an event). 11, 46, 14, and 1 instances of broadband emission event out of 1048 total sonications for P Avg , P Max , CL, and ML‐CL, respectively. (J) MLP decision histogram for ML‐CL. 4.4% positive predictions. (46/1040 of sonication). (K) Treatment window analysis for reactive (OL, CL) and predictive (ML‐CL) controllers, showing a ∼300% expansion with ML‐CL (0.09 vs. 0.02 MPa for OL/CL) and a 188% shift in K trans ‐to‐broadband probability curve, indicating improved BBB opening at matched safety. A more detailed figure with individual data points is shown in Figure . ns = not significant, * p < 0.05, and ** p < 0.01. Statistical analyses were performed through One‐way ANOVA and Bonferroni correction. For the variance test, f ‐test was used with Bonferroni correction.

Journal: Advanced Science

Article Title: Data‐Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain

doi: 10.1002/advs.202517834

Figure Lengend Snippet: Treatment window expansion by ML‐CL. (A) Experimental workflow for all MB‐FUS controllers. (B) Cavitation threshold model from the training dataset, showing 7th harmonic AE vs. pressure; 36 dB target level was chosen above the model. (C) ML‐CL pressure decisions (left) and corresponding P Max and P Avg used for OL controllers (right); OL's pressure reduction indicates response to broadband emission events (> 6 dB). D) Representative MRI image for 36 dB target level sonication targets. Total 4 targets per mouse. (E) 7th harmonic emissions during sonication for each controller. P Avg :36.2 ± 3.3 dB, P Max 37.9 ± 2.4 dB, CL:35.1 ± 0.7 dB, ML‐CL:34.7 ± 0.7 dB. n = 8 targets (total 2 animals) per group. (F) Mean (left) and standard deviation (right) of 7 th harmonic emission during sonication by ML‐CL. A variance test ( f ‐test) was performed to compare the standard deviation (right) of the mean 7th harmonic emission at each target. (G) MRI T1 images using the controller at 36 dB or equivalent OL pressure. (H) Quantification of K trans values through DCE‐MRI. (I) Broadband emission histogram (>6 dB considered an event). 11, 46, 14, and 1 instances of broadband emission event out of 1048 total sonications for P Avg , P Max , CL, and ML‐CL, respectively. (J) MLP decision histogram for ML‐CL. 4.4% positive predictions. (46/1040 of sonication). (K) Treatment window analysis for reactive (OL, CL) and predictive (ML‐CL) controllers, showing a ∼300% expansion with ML‐CL (0.09 vs. 0.02 MPa for OL/CL) and a 188% shift in K trans ‐to‐broadband probability curve, indicating improved BBB opening at matched safety. A more detailed figure with individual data points is shown in Figure . ns = not significant, * p < 0.05, and ** p < 0.01. Statistical analyses were performed through One‐way ANOVA and Bonferroni correction. For the variance test, f ‐test was used with Bonferroni correction.

Article Snippet: To access the vessel permeability in the brain, we measured the volume transfer constant, K trans , by performing DCE‐MRI ( Pharmascan 7T, Bruker , IR, echo time, 2.5 ms; rep time, 1019.6 ms; flip angle, 30; FOV, 20 × 20 mm 2 for mice, 35 × 35 mm 2 for rats) after the last sonication.

Techniques: Sonication, Standard Deviation